Tempest Therapeutics, Inc. (TPST) Misses Q3 EPS by 5c

Tempest Therapeutics, Inc. (NASDAQ: TPST) reported Q3 EPS of ($0.41), $0.05 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Fannie Mae loses at least 10 senior executives amid departures - WSJ
• FTC files amicus brief challenging Amgen's Enbrel patent acquisition